98%
921
2 minutes
20
Growing evidence indicates that exposure to arsenic could be linked to immune-related issues. Nevertheless, the relevant molecular mechanisms are not well understood. To explore the impacts of acute exposure to sodium arsenite (NaAsO) on transcription factors and cytokines related to the differentiation of CD4 T cell subsets in mice immune organs, as well as the potential mechanism underlying the arsenic immunotoxicity. Female C57BL/6 mice received intragastric exposure to NaAsO at doses of 2.5, 5, and 10 mg/kg for a duration of 24 h to observe the changes in inflammatory reactions, CD4 T cell differentiation, and TLR-DAMP interactions using the assayed method of flow cytometry, ELISA, real-time PCR, and western blot. Arsenic markedly reduced the weights and indices of the spleen and thymus, and flow cytometry revealed that arsenic decreased the relative frequency of CD4 T cell subpopulation and the ratios of CD4/CD8 in spleen. Arsenic up-regulated serum pro-inflammatory cytokine levels of tumor necrosis factor α (TNF-α), IL-1β, and IL-6, as well as mRNA levels of TNF-α, IL-1β, and IL-6 within the spleen and thymus. Additionally, the expression of T helper 1 (Th1), Th2, and regulatory T cell (Treg) related transcription factors and cytokines was markedly increased in arsenic-treated mice, whereas the expression of Th17-related transcription factors and cytokines were markedly decreased in arsenic-treated mice when in comparison to the group of control. Moreover, arsenic remarkably elevated the expression of proteins that participated within the DAMPs-TLR4/NF-κB signaling pathway including TLR4, MD2, MyD88, and NF-κB. Acute arsenic exposure-induced variation of inflammatory reactions and CD4 T cell subsets differentiation is probably correlated with activation of the DAMPs-TLR4/NF-κB signaling pathway.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1007/s10653-025-02622-6 | DOI Listing |
Blood Adv
September 2025
BC Cancer, Vancouver, British Columbia, Canada.
Classical Hodgkin Lymphoma (CHL) is characterized by a complex tumor microenvironment (TME) that supports disease progression. While immune cell recruitment by Hodgkin and Reed-Sternberg (HRS) cells is well-documented, the role of non-malignant B cells in relapse remains unclear. Using single-cell RNA sequencing (scRNA-seq) on paired diagnostic and relapsed CHL samples, we identified distinct shifts in B-cell populations, particularly an enrichment of naïve B cells and a reduction of memory B cells in early-relapse compared to late-relapse and newly diagnosed CHL.
View Article and Find Full Text PDFInfect Immun
September 2025
Institute of Medical Microbiology and Hospital Hygiene, Heinrich Heine University, Düsseldorf, Germany.
Lymphotoxin β receptor (LTβR/TNFRSF3) signaling plays a crucial role in immune defense. Notably, LTβR-deficient (LTβR) mice exhibit severe defects in innate and adaptive immunity against various pathogens and succumb to infection. Here, we investigated the bone marrow (BM) and peritoneal cavity (PerC) compartments of LTβR mice during infection, demonstrating perturbed B-cell and T-cell subpopulations in the absence of LTβR signaling.
View Article and Find Full Text PDFJ Exp Med
November 2025
Department of Microbiology and Immunology, Stanford University School of Medicine, Stanford, CA, USA.
Host-pathogen interactions involve two critical strategies: resistance, whereby hosts clear invading microbes, and tolerance, whereby hosts carry high pathogen burden asymptomatically. Here, we investigate mechanisms by which Salmonella-superspreader (SSP) hosts maintain an asymptomatic state during chronic infection. We found that regulatory T cells (Tregs) are essential for this disease-tolerant state, limiting intestinal immunopathology and enabling SSP hosts to thrive, while facilitating Salmonella transmission.
View Article and Find Full Text PDFNeurol Res
September 2025
Henan Provincial People's Hospital, Department of Surgery of Spine and Spinal Cord, People's Hospital of Zhengzhou University, Zhengzhou, China.
Background: Immunotherapy holds significant yet underexplored potential for low-grade glioma (LGG) treatment. We therefore interrogated the role of Fanconi Anemia Complementation Group C (FANCC) as a novel immune checkpoint regulator given its spatial correlation with tumor microenvironments and clinical associations with immunosuppressive markers.
Objectives: FANCC is implicated in various tumor progressions; its role in LGG remains unexplored.
Biotechnol J
September 2025
Department of Biochemical Engineering, University College London, London, UK.
Chimeric antigen receptor T-cell (CAR-T) therapies have demonstrated clinical efficacy in treating haematological malignancies, resulting in multiple regulatory approvals. However, there is a need for robust manufacturing platforms and the use of GMP-aligned reagents to meet the clinical and commercial demands. This study investigates the impact of serum/xeno-free medium (SXFM) and cytokine supplementation on CAR-T cell production in static and agitated culture systems, using 24-well plate G-Rex vessels and 500 mL stirred tank bioreactors (STRs), respectively.
View Article and Find Full Text PDF